Your browser doesn't support javascript.
loading
Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.
Wachsmann, Tassilo L A; Meeuwsen, Miranda H; Remst, Dennis F G; Buchner, Karen; Wouters, Anne K; Hagedoorn, Renate S; Falkenburg, J H Frederik; Heemskerk, Mirjam H M.
Afiliação
  • Wachsmann TLA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Meeuwsen MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Remst DFG; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Buchner K; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Wouters AK; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hagedoorn RS; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Falkenburg JHF; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Heemskerk MHM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
Blood Adv ; 7(20): 6178-6183, 2023 10 24.
Article em En | MEDLINE | ID: mdl-37567150

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda